University Hospital
Clermont-Ferrand, 63100, France
NCT Number: NCT06448000
Sperm cryopreservation is an essential tool for men fertility preservation in the context of gonadotoxic treatments or/and pathologies such as cancers, gamete donation and ART. Nevertheless, it is validated that the freezing and thawing procedures affect sperm parameters and in particular motility. It is therefore essential to determine the impact of storage time on motility and particularly the number of progressive motile spermatozoa which will determine the choice of ART technique. However, few studies have analyzed the impact of storage time in liquid nitrogen and no study over a long period on human spermatozoa and their use in ART.
The aim of this study is to assess the impact of long-time storage, from 2 to 12 years, in liquid nitrogen on standard semen parameters, notably motility.
Looking for future studies?
Notify Me19 year–63 year
Male
Observational
Clermont-Ferrand, 63100, France
It has been demonstrated in the literature that cryopreservation of semen samples in liquid nitrogen guaranty good post thawing motility recovery. However, the literature is scarce and relatively old. Moreover, studies only described very small samples cohort and do not specify in which container the samples are stored. There are currently no published studies on high security straws which are widely used for semen cryopreservation worldwide.
The aim of this study is to assess the impact of long-time storage, from 2 to 12 years, in high security straws, in liquid nitrogen on human standard semen parameters, notably on motility.
Hundred and one cryopreserved semen samples between 2010 to 2020 were donated to research by patients monitored in the unit of Assisted Reproductive Technology - Conservation of human sperm and eggs (ART-CECOS) Unit of the University Hospital of Clermont-Ferrand for fertility preservation. Only samples corresponding to the inclusion criteria below were included in the study without distinction of bio clinical criteria.
All analyzed samples have been cryopreserved following the same protocol, in high security 0,3ml straws, with the same cryoprotectant and using the same programmable freezer Nanodigitcool (CryoBiosystem).
The day of cryopreservation, a post-freezing test (T0) was caried by thawing a straw and by assessing sperm count, motility and vitality according to WHO guidelines 2010.
After a storage time from 2 to 12 years, a second post-freezing test (T1) was caried by thawing two straws and by assessing sperm count, motility and vitality in the same way as T0.
The statistical difference, concordance, correlation and diagnostic agreement between T0 and T1 were analyzed.
This study is the first to assess the integrity of human sperm after a long-time cryopreservation in liquid nitrogen on a large cohort (more than 100 samples).
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 07/2022 to 03/2023
The percentage of total and progressive motile human spermatozoa were assessed according to WHO, 2010 guideline.
Time frame: 07/2022 to 03/2023
The percentage of alive human spermatozoa were assessed according to WHO, 2010 guideline.
Time frame: 07/2022 to 03/2023
The number of motile human spermatozoa were assessed according to WHO, 2010 guideline.
University Hospital, Clermont-Ferrand
Other
Impact of Storage Time in Liquid Nitrogen on Cryopreserved Human Spermatozoa
Acronym: CRYOFERT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05385718
Cancer, Healthy
Beverly Hills, California, United States
View Trial DetailsNCT06123416
Breast Cancer, Breast Diseases
Stanford, California, United States
View Trial DetailsNCT01142037
Cancer, Healthy
Saint Paul, Minnesota, United States
View Trial DetailsNCT00878735
Anxiety Disorders, Behavior
São Paulo, Brazil
View Trial Details